Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TTLL11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MAPK11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM69B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBEAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EML3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORBS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505949 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC642361 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MLXIPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTYH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C7orf26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM120B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAGHL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPIRE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on